Nattokinase-promoted tissue plasminogen activator release from human cells

Pathophysiology of Haemostasis and Thrombosis

Volumn 36, Issue 5, 2008, Pages 227-232

  Yatagai, Chieko ^a,b   Maruyama, Masugi ^b   Kawahara, Tomoko ^a   Sumi, Hiroyuki ^a  

^a KURASHIKI UNIVERSITY OF SCIENCE AND THE ARTS   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Bacillus subtilis natto; Human vascular endothelial cell; Nattokinase; Tissue plasminogen activator

Indexed keywords

NATTOKINASE; PLASMIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; FIBRINOLYTIC AGENT; SUBTILISIN;

ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; CELL COUNT; ENZYME ACTIVITY; ENZYME SUBSTRATE; FIBRINOLYSIS; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYMOLOGY; HEAT; METABOLISM;

BACILLUS SUBTILIS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; HELA CELLS; HOT TEMPERATURE; HUMANS; SUBTILISINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 77449134531     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000252817     Document Type: Article

References (21)

1. Sumi H, Hamada H, Tsushima H, Mihara H, Muraki H: A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a typical and popular soybean food in the Japanese diet. Experientia 1987; 43: 1110-1111.
2. Sumi H, Hamada H, Nakanishi K, Hiratani H: Enhancement of fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol 1990; 84: 139-143.
3. Sumi H: Regarding current research trends for the functionality of nattokinase. Food Style 21 2006; 10: 1-5.
4. Sumi H: The history and functional components of nattö. Jpn J Taste Smell Res 2007; 14: 129-136.
5. Sumi H, Yatagai C: Fermented soybean components and disease prevention; in Sugano M (ed): Soy in Health and Disease Prevention. Boca Raton, Taylor & Francis, 2005, pp 251-278.
6. Arts J, Herr I, Lansink M, Angel P, Kooistra T: Cell-type specific DNA protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro. Nucleic Acids Res 1997; 25: 311-317.
7. Waller EK, Schleuning WD: Induction of fibrinolytic activity in HeLa cells by phorbol myristate acetate. J Biol Chem 1985; 260: 6354-6360.
8. Astrup T, Müllertz S: The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 1952; 40: 346-351.
9. Granelli-Piperno A, Reich E: A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med 1952; 40: 346-351.
10. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol- chloroform extraction. Anal Biochem 1987; 162: 156-159.
11. Medcalf RL, Rüegg M, Schleuning WD: A DNA motif related to the cAMP-responsive element and an exon- located activator protein- 2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP. J Biol Chem 1990; 265: 14618-14626.
12. Fisher RA: Statistical Methods for Research Workers, ed 13. New York, Hafner Publishing, 1958, pp 122-128.
13. Ohsugi T, Ikeda S, Sumi H: Anti-platelet aggregation and anti-blood coagulation activities of dipicolinic acid, a sporal component of Bacillus subtilis natto . Food Sci Technol Res 2005; 11: 308-310.
14. Ikeda S, Ohsugi T, Sumi H: Activation of fibrinolysis (nattokinase) induced by dipicolinic acid and related compounds. Food Sci Technol Res 2006; 12: 152-155.
15. Sumi H, Ikeda S, Ohsugi T: Increasing the production of nattokinase and vitamin K 2 on natto with dipicolinic acid. Open Food Sci J 2008; 2: 151-155.
16. Hagiwara H, Shimonaka M, Morisaki M, Ikekawa N, Inada Y: Sitosterol-stimulative production of plasminogen activator in cultured endothelial cells from bovine carotid artery. Thromb Res 1984; 33: 363-370. (Pubitemid 14158926)
17. Schneider J: Stimulation of plasma fibrinolytic activity in rats by the prostacyclin analogue CG 4203. Thromb Res 1987; 48: 233-244.
18. Motoyama Y, Sakata Y, Seki J, Sato M, Namikawa Y, Horiai H, Ono T: TFC-612, a prostaglandin E 1 derivative, enhances fibrinolytic activity in rats. Thromb Res 1992; 65: 55-62.
19. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA: Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 1998; 4: 228-231.
20. Matys T, Pawlak R, Matys E, Pavlides C, McEwen BS, Strickland S: Tissue plasminogen activator promotes the effects of corticotropin- releasing factor on the amygdala and anxiety-like behavior. Proc Natl Acad Sci USA 2004; 101: 16345-16350.
21. Maeia J, Mikzynska M, Sladek K, Cierniewski CS, Nizankowski R, Szczeklik A: Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease. Prostaglandins 1986; 31: 61-70.